Medipaams

Pharmaceutical manufacturing and distribution of medicines for domestic and international markets.

About Medipaams

Medipaams is a Healthcare company. Pharmaceutical manufacturing and distribution of medicines for domestic and international markets. Its Indian entity Medipaams India Private Limited reported revenue of β‚Ή4.52 Cr. Medipaams offers products and services including Injectables and Tablets. Its focus areas include Pharmaceuticals, Medicine Manufacturing, Drug Distribution and International Export.

Company details

Medipaams is recognized as a Mumbai-based pharmaceutical company that has maintained a market presence since 1982. It specializes in the development, manufacturing, and distribution of high-quality medicines for both domestic and international markets. Products are designed to enhance the health and wellbeing of people globally, with a commitment to innovative processes and adherence to Good Manufacturing Practices. Raw materials of varied quality are utilized, and the company ensures affordability and on-time supply through its extensive network across Africa, Asia, Latin America, and other regions. Quality assessments are regularly performed by qualified personnel to uphold efficacy and standards.

Key Metrics
  • Indian entity revenue
    ₹4.52 Cr

    FY 2024 · +13% YoY

  • Indian entity net profit
    ₹1.4 Lakh

    FY 2024 · 0% margin

  • Indian entity EBITDA
    ₹2.4 Lakh

    FY 2024 · 1% margin

Products & Services of Medipaams

Medipaams offers a comprehensive portfolio of products and services, including Injectables and Tablets.

Injectables
Pharmaceutical Products

Injectables are manufactured and distributed for various medical applications to support patient care in healthcare settings

Tablets
Pharmaceutical Products

Tablets are produced and supplied for general and critical care purposes, ensuring accessibility in domestic and global markets

Board of directors of Medipaams India Private Limited (Medipaams)

Medipaams India Private Limited is the primary company behind Medipaams. The board of Medipaams India Private Limited currently have 2 directors; the longest-serving is Alpesh Munani Popatlal, appointed in 2005. 4 earlier directors have ceased.

DirectorDesignationAppointedTenureEntity
Alpesh Munani Popatlal
DIN 01206597
Director03 Aug 200521 yrs 3 moMedipaams India Private Limited
Abhi Alpesh Munani
DIN 08438754
Director18 May 20206 yrs 6 moMedipaams India Private Limited

Financials of Medipaams

Figures of Medipaams India Private Limited, the primary company behind Medipaams, for FY 2024. Revenue was ₹4.52 Cr (+13% year on year). Net profit was ₹1.4 Lakh (0% margin). EBITDA was ₹2.4 Lakh (1% margin). Revenue has grown at a compounded annual rate of +41% over three years and +17% over five years.

  • ₹4.52 CrRevenue · FY 2024 · +13% YoY
  • ₹1.4 LakhNet profit · 0% margin
  • ₹2.4 LakhEBITDA · 1% margin
  • ₹1 LakhPaid-up capital
  • +41%Revenue CAGR, 3 years
  • +17%Revenue CAGR, 5 years

Balance sheet, profit and loss, cash flow and ratios of Medipaams India Private Limited are on its company page.

Premium access

Detailed financial statements for Medipaams

Statement rows, ratios, five-year trends and downloadable financials of the group companies require an active premium plan.

  • Statement rows
  • Financial ratios
  • Five-year trends
  • Downloads

Verified entity values are shown only after access is granted.

Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track β€” from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • βœ“
    Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • βœ“
    Full access to every database India & global coverage, advanced filters and rich profile details
  • βœ“
    Always-on access from your team account Single premium plan for everything you see on the portal

Frequently Asked Questions about Medipaams

The primary company behind Medipaams, Medipaams India Private Limited, reported revenue of β‚Ή4.52 Cr for FY 2024, up 13% year on year.

Medipaams is recognized as a Mumbai-based pharmaceutical company that has maintained a market presence since 1982. It specializes in the development, manufacturing, and distribution of high-quality medicines for both domestic and international markets. Products are designed to enhance the health and wellbeing of people globally, with a commitment to innovative processes and adherence to Good Manufacturing Practices. Raw materials of varied quality are utilized, and the company ensures affordability and on-time supply through its extensive network across Africa, Asia, Latin America, and other regions. Quality assessments are regularly performed by qualified personnel to uphold efficacy and standards.

Medipaams offers Injectables and Tablets.

Medipaams operates through Medipaams India Private Limited.

The legal entities of Medipaams currently have 2 directors, including Alpesh Munani Popatlal, Abhi Alpesh Munani.

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available